Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.

By L. Stewart, Mike Clarke, Maroeska M. Rovers, R. Riley, M. Simmonds, Gavin B. Stewart, J. Tierney. Journal of the American Medical Association (JAMA), 2015

1,945 citations recorded by the source corpus.

Subfields: Experimental and Cognitive Psychology, General Health Professions, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/95f5d3c76cd57b2716f13e2839f6a6f93387928e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Experimental and Cognitive Psychology

In General Health Professions

In Statistics and Probability

Citations in the corpus

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China (2020, methodology): “Preferred Reporting Items for Systematic Reviews and MetaAnalyses of individual participant data (the PRISMA-IPD) statement was followed for the conduct and reporting of this meta-analysis [12].”
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. (2020, methodology): “We constructed a sampling frame, consisting of all members of the PRISMA 2009 and PRISMA for Protocols (PRISMA-P) 2015 Groups (25, 26), corresponding authors of all PRISMA extensions that were published (27-34) or in development at the time of the survey (35-38), editors in chief and associate edito”
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021, methodology): “Finally, extensions to the PRISMA 2009 statement have been developed to guide reporting of network metaanalyses,[49] meta-analyses of individual participant data,[50] systematic reviews of harms, [51] systematic reviews of diagnostic test accuracy studies, [52] and scoping reviews [53]; for these ty”
Preferred reporting items for systematic reviews and meta‐analyses in ecology and evolutionary biology: a PRISMA extension (2021, methodology): “Several extensions of PRISMA have been published to suit different types of reviews (e.g. PRISMA for Protocols, PRISMA for NetworkMeta-Analyses, and PRISMA for individual patient data: Hutton et al., 2015; Moher et al., 2015; Stewart et al., 2015).”
External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges (2016, background): “76 Graphical displays presenting model performance are particularly important.”
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. (2021, methodology): “Finally, extensions to the PRISMA 2009 statement have been developed to guide reporting of network meta-analyses [49] , meta-analyses of individual participant data [50] , systematic reviews of harms [51] , systematic reviews of diagnostic test accuracy studies [52] , and scoping reviews [53] ; for ”
Efficacy of Self-guided Internet-Based Cognitive Behavioral Therapy in the Treatment of Depressive Symptoms: A Meta-analysis of Individual Participant Data (2017, methodology): “Study Identification and Selection Process The analysis was completed in compliance with the Preferred Reporting Items for Systematic Review and Metaanalyses (PRISMA) IPD Statement.(17) We used an existing database on psychological treatments for depression(18) that is updated annually by a systemat”
The COMET Handbook: version 1.0 (2017, background): “ual participant data [183], the next step will be the active encouragement by journals of the use of COS in re-”